LSE:SN. (Smith & Nephew plc)

About SN.

Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.
  • Smith & Nephew plc (LSE: SN.) Latest News

    Dividend Shares

    This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

    Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

    Read more »

    Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
    Investing Articles

    Down 21%, is the Smith & Nephew share price too cheap to ignore?

    The Smith & Nephew share price is trading at its cheapest for almost a year. Is now the time for…

    Read more »

    Middle-aged white man pulling an aggrieved face while looking at a screen
    Investing Articles

    After crashing 13% in a day, is Smith & Nephew now a ‘no-brainer’ value stock?

    This FTSE 100 share plunged today, leaving our writer to wonder if there's an enticing value stock staring him right…

    Read more »

    A senior woman sits up on the exam table at a doctors appointment. She is dressed casually in a blue sweater and has a smile on her face as she glances at the doctor. Her female doctor is wearing a white lab coat and seated in front of her as she takes notes on a tablet.
    Investing Articles

    As Smith & Nephew shares tumble, is it time to buy?

    The Smith & Nephew shares led the FTSE 100 loser board this morning after a trading update. Does this offer…

    Read more »

    Investing Articles

    Can this Q3 update get the Smith & Nephew share price moving again?

    After a few tough years blighted by the pandemic, the outlook might be getting a bit brighter for the Smith…

    Read more »

    Investing Articles

    Looking for stock market bargains? 2 FTSE 100 shares to consider buying today

    Ben McPoland highlights a pair of FTSE shares that appear undervalued to him when seen from a Foolish long-term perspective.

    Read more »

    Investing Articles

    3 competitors Fool believe will outperform Tesla stock over the next 5 years

    Tesla is probably the most volatile stock in the Magnificent Seven stock: just take a look at its share-price chart…

    Read more »

    Young Caucasian man making doubtful face at camera
    Investing Articles

    Here’s where I think the FTSE 100 will be in 5 years

    Edward Sheldon examines returns from the FTSE 100 over the last 20 years and projects where the blue-chip index could…

    Read more »

    Senior woman potting plant in garden at home
    Top Stocks

    4 robotics stocks Fools think could deliver explosive growth

    These stocks are appealing for their growth potential, given the increasing adoption of robotics across various industries.

    Read more »

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    One of my favourite FTSE 100 stocks is down 42%. But it’s now making a rapid recovery

    This FTSE 100 stock was absolutely crushed in the pandemic. But it now appears to be in the early stages…

    Read more »

    A senior woman sits up on the exam table at a doctors appointment. She is dressed casually in a blue sweater and has a smile on her face as she glances at the doctor. Her female doctor is wearing a white lab coat and seated in front of her as she takes notes on a tablet.
    Investing Articles

    Is it time for me to buy this rallying FTSE 100 stock? Bank of America thinks so!

    Major brokers are getting excited about this troubled FTSE 100 stock. I decided to find out what the fuss is…

    Read more »

    Person holding magnifying glass over important document, reading the small print
    Investing Articles

    Down 8%, is this a rare opportunity to buy this overlooked FTSE powerhouse stock?

    Despite strong H1 results, this FTSE 100 medical technology heavyweight’s shares have fallen, and now look even more undervalued to…

    Read more »